EC Accuses J&J, Novartis of Pay-for-Delay Agreements for Fentanyl

Drug Industry Daily
A A
The European Commission (EC) accused Johnson & Johnson (J&J) and Novartis of anticompetitive “pay-for-delay” agreements between their respective Dutch subsidiaries on fentanyl.

To View This Article:

Login

Subscribe To Drug Industry Daily